Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 3/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | PKM | P14618 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | EGFR | P00533 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12797842 | 0.81 | SMN1; SMN2 (0.40) | SMN1; SMN2MAPTALDH1A1CYP2D6MEN1 | |
| SCHEMBL3073514 | 0.80 | SMN1; SMN2 (0.38) | SMN1; SMN2MAPTALDH1A1MEN1KMT2A | |
| SCHEMBL13420882 | 0.77 | MAPT (0.39) | SMN1; SMN2MAPTALDH1A1CYP2D6MEN1 | |
| SCHEMBL12797945 | 0.76 | SMN1; SMN2 (0.39) | SMN1; SMN2MAPTALDH1A1CYP2D6MEN1 | |
| SCHEMBL12797900 | 0.73 | SMN1; SMN2 (0.38) | SMN1; SMN2MAPTALDH1A1CYP2D6MEN1 | |
| SCHEMBL18222309 | 0.71 | SMN1; SMN2 (0.33) | SMN1; SMN2MAPTALDH1A1CYP2D6PKM | |
| SCHEMBL12797935 | 0.69 | SMN1; SMN2 (0.42) | SMN1; SMN2MAPTALDH1A1CYP2D6MEN1 | |
| SCHEMBL12797899 | 0.69 | SMN1; SMN2 (0.37) | SMN1; SMN2MAPTALDH1A1CYP2D6MEN1 | |
| SCHEMBL12797901 | 0.69 | SMN1; SMN2 (0.37) | SMN1; SMN2MAPTALDH1A1CYP2D6MEN1 | |
| SCHEMBL12797950 | 0.68 | SMN1; SMN2 (0.40) | SMN1; SMN2MAPTALDH1A1CYP2D6MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1732895-B1 | INSECTICIDAL N-SUBSTITUTED SULFOXIMINES | DOW AGROSCIENCES LLC (US) | 2016-11-16 | — | — | EP | disclosed |
| US-7897782-B2 | [3-(6-Chloropyridin-3-yl)-2-methylpropyl](methyl)oxido- lambda 4-sulfanylidenecyanamide; aphidicides | DOW AGROSCIENCES LLC (US) | 2011-03-01 | — | — | US | disclosed |
| US-7834188-B2 | Insecticidal N-substituted sulfoximines | DOW AGROSCIENCES LLC (US) | 2010-11-16 | — | — | US | disclosed |
| US-7829719-B2 | Insecticidal N-substituted sulfoximines | DOW AGROSCIENCES LLC (US) | 2010-11-09 | — | — | US | disclosed |
| US-7795456-B2 | Insecticidal N-substituted sulfoximines | DOW AGROSCIENCES LLC (US) | 2010-09-14 | — | — | US | disclosed |
| US-20100076032-A1 | INSECTICIDAL N-SUBSTITUTED SULFOXIMINES | DOW AGROSCIENCES LLC (US) | 2010-03-25 | — | — | US | disclosed |
| US-7678920-B2 | Insecticidal N-substituted sulfoximines | DOW AGROSCIENCES LLC (US) | 2010-03-16 | — | — | US | disclosed |
| US-20100063136-A1 | INSECTICIDAL N-SUBSTITUTED SULFOXIMINES | DOW AGROSCIENCES LLC (US) | 2010-03-11 | — | — | US | disclosed |
| US-20100056578-A1 | INSECTICIDAL N-SUBSTITUTED SULFOXIMINES | DOW AGROSCIENCES LLC (US) | 2010-03-04 | — | — | US | disclosed |
| US-20100056579-A1 | INSECTICIDAL N-SUBSTITUTED SULFOXIMINES | DOW AGROSCIENCES LLC (US) | 2010-03-04 | — | — | US | disclosed |
| US-20050228027-A1 | Insecticidal N-substituted sulfoximines | CORTEVA AGRISCIENCE LLC | 2005-10-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100056579-A1 | INSECTICIDAL N-SUBSTITUTED SULFOXIMINES | GSS, STS, SMS | SMN1; SMN2 253/4885MAPT 4687/4885ALDH1A1 3325/4885 |
| US-20100076032-A1 | INSECTICIDAL N-SUBSTITUTED SULFOXIMINES | GSS, STS, SMS | SMN1; SMN2 253/4885MAPT 4687/4885ALDH1A1 3325/4885 |
| US-20100063136-A1 | INSECTICIDAL N-SUBSTITUTED SULFOXIMINES | GSS, STS, SMS | SMN1; SMN2 253/4885MAPT 4687/4885ALDH1A1 3325/4885 |
| US-20100056578-A1 | INSECTICIDAL N-SUBSTITUTED SULFOXIMINES | GSS, STS, SMS | SMN1; SMN2 253/4885MAPT 4687/4885ALDH1A1 3325/4885 |
| US-20050228027-A1 | Insecticidal N-substituted sulfoximines | GSS, STS, SMS | SMN1; SMN2 253/4885MAPT 4687/4885ALDH1A1 3325/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.